Performance and Safety of Routine Cataract Surgery With Visiol

NCT04866706 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2023-11-22

No results posted yet for this study

Summary

In this clinical investigation, the performance and safety of routine cataract surgery with VISIOL will be assessed

Conditions

  • Following Cataract Surgery

Interventions

DEVICE

Visiol

VISIOL is a 2.0% (m/v) SH viscoelastic solution used for ocular surgery.

Sponsors & Collaborators

  • TRB Chemedica

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-27
Primary Completion
2022-12-09
Completion
2023-10-27

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04866706 on ClinicalTrials.gov